Skip to main content

Daily Screen Time Tied to Higher Myopia Risk

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 25, 2025.

By Lori Solomon HealthDay Reporter

TUESDAY, Feb. 25, 2025 -- The risk for myopia increases significantly with one to four hours of daily exposure to screen time, according to a review published online Feb. 21 in JAMA Network Open.

Ahnul Ha, M.D., from Jeju National University Hospital in Jeju-si, South Korea, and colleagues conducted a systematic literature review to characterize the association between digital screen time and myopia risk.

Based on 45 studies (335,524 participants), a linear random-effects, dose-response meta-analysis (DRMA) showed an additional hour of daily screen time was associated with higher odds of myopia (odds ratio, 1.21). The nonlinear DRMA among 34 studies (314,910 participants) also indicated higher odds of myopia with increasing screen time, ranging from one hour of daily exposure (odds ratio, 1.05) to four hours of daily exposure (odds ratio, 1.97). Myopia risk increased significantly between one to four hours of daily screen time in a dose-response curve, and then rose more gradually after four hours.

"These findings can offer guidance for clinicians and researchers and underscore the need to refine dose-response models for digital screen time and myopia risk to better address the myopia pandemic," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted February 2025

Read this next

Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections

WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...

AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer

TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...

AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors

TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.